+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

ADME Toxicology Testing Market - Product Thumbnail Image

ADME Toxicology Testing Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
PEGylated Proteins Market - Product Thumbnail Image

PEGylated Proteins Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Biosimulation Market - Product Thumbnail Image

Biosimulation Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region - Product Thumbnail Image

Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Asia Pacific Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Biosimulation Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Asia Pacific
From
Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Biosimulation Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Optical Preclinical Imaging Market Report and Forecast 2024-2032 - Product Thumbnail Image

Optical Preclinical Imaging Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Peptide Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Peptide Therapeutics Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Microbiome Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Microbiome Therapeutics Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Biopharmaceuticals Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Europe Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User - Product Thumbnail Image

Europe Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User

  • Report
  • April 2024
  • 71 Pages
  • Europe
From
North America Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User - Product Thumbnail Image

North America Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User

  • Report
  • April 2024
  • 68 Pages
  • North America
From
South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis - by Service Type and End-User - Product Thumbnail Image

South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis - by Service Type and End-User

  • Report
  • January 2024
  • 95 Pages
From
Microbiome Therapeutics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Type, Application, End User, and Geography - Product Thumbnail Image

Microbiome Therapeutics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Type, Application, End User, and Geography

  • Report
  • November 2023
  • 160 Pages
  • Global
From
NGS-Based RNA-Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

NGS-Based RNA-Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
B-Cell Maturation Antigen Targeted Therapies - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

B-Cell Maturation Antigen Targeted Therapies - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Chimeric Antigen Receptor (CAR) T-Cell Therapy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
CAR T-Cell Therapy for Multiple Myeloma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

CAR T-Cell Therapy for Multiple Myeloma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2024
  • 174 Pages
  • Global
From
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

CAR T-Cell Therapy for Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more